CASP3 and Alzheimer disease: In AD transgenic mouse model that overexpress human mutant APP, Aβ accumulation has been shown to lead to aberrant caspase-3 activation triggering a cascade of down-stream signaling events leading to synaptic loss and behavioral changes [67, 68].